NCT00003490View on ClinicalTrials.gov

Combination Chemotherapy Following GM-CSF in Treating Patients With Multiple Myeloma

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 1998

Study Completion Date

August 31, 2003

Conditions
Multiple Myeloma and Plasma Cell Neoplasm
Interventions
BIOLOGICAL

sargramostim

DRUG

cyclophosphamide

DRUG

prednisone

DRUG

vincristine sulfate

Trial Locations (1)

44195

Cleveland Clinic Cancer Center, Cleveland

All Listed Sponsors
lead

The Cleveland Clinic

OTHER

NCT00003490 - Combination Chemotherapy Following GM-CSF in Treating Patients With Multiple Myeloma | Biotech Hunter | Biotech Hunter